Product Information
METHYLPHENIDATE 10 MG/5 ML SOL is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $0.1199 per ML under NDC 70752013214. Its NADAC has been published 309 times since Aug 12, 2020.
FDA first approved this application on Jun 4, 2020. Its Orange Book therapeutic-equivalence code is AA.
Strength
10 mg/5mL
Manufacturer
Quagen Pharmaceuticals LLCNDC
70752013214
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213567FDA Approved
6/4/2020
TE Code
AA
On Market Since
6/4/2020
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 10 MG/5 ML SOL has been published 309 times since Aug 12, 2020, and over the history we have for it it has declined 32.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1199 per ML |
|---|---|
| All-time high | $0.2056 (Jun 15, 2022) |
| All-time low | $0.0932 (Nov 20, 2024) |
| 52-week high | $0.1241 |
| 52-week low | $0.1106 |
| Median price | $0.1241 |
| Average price | $0.1375 |
| Largest weekly change | +49.8% (Jun 21, 2023) |
| Weeks tracked | 309 |
| Tracking since | Aug 12, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the METHYLPHENIDATE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quagen Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METHYLPHENIDATE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 10 MG/5 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 10 MG/5 ML SOL, manufactured by Quagen Pharmaceuticals LLC, is $0.1199 per ML (NDC 70752013214), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE 10 MG/5 ML SOL changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 10 MG/5 ML SOL has declined 32.3%. It has been tracked across 309 weekly CMS publications since Aug 12, 2020.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 10 MG/5 ML SOL?
Since Aug 12, 2020, the NADAC for METHYLPHENIDATE 10 MG/5 ML SOL has ranged from a low of $0.0932 (Nov 20, 2024) to a high of $0.2056 (Jun 15, 2022), with a median of $0.1241 per ML.
Are there cheaper alternatives to METHYLPHENIDATE 10 MG/5 ML SOL?
No other NADAC-published product currently shares the active ingredient and strength of METHYLPHENIDATE 10 MG/5 ML SOL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METHYLPHENIDATE 10 MG/5 ML SOL?
METHYLPHENIDATE 10 MG/5 ML SOL (NDC 70752013214) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.